These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33153174)

  • 1. Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases.
    Rysz J; Franczyk B; Ławiński J; Gluba-Brzózka A
    Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33153174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation.
    Wojtaszek E; Oldakowska-Jedynak U; Kwiatkowska M; Glogowski T; Malyszko J
    Oxid Med Cell Longev; 2021; 2021():6651367. PubMed ID: 33628373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease (NAFLD)--is it a new marker of hyporesponsiveness to recombinant human erythropoietin in patients that are on chronic hemodialysis?
    Orlic L; Mikolasevic I; Lukenda V; Racki S; Stimac D; Milic S
    Med Hypotheses; 2014 Dec; 83(6):798-801. PubMed ID: 25456789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms and Modulation of Oxidative/Nitrative Stress in Type 4 Cardio-Renal Syndrome and Renal Sarcopenia.
    Sárközy M; Kovács ZZA; Kovács MG; Gáspár R; Szűcs G; Dux L
    Front Physiol; 2018; 9():1648. PubMed ID: 30534079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative Stress in Non-Dialysis-Dependent Chronic Kidney Disease Patients.
    Tomás-Simó P; D'Marco L; Romero-Parra M; Tormos-Muñoz MC; Sáez G; Torregrosa I; Estañ-Capell N; Miguel A; Gorriz JL; Puchades MJ
    Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
    Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
    Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis.
    Levin A
    Semin Dial; 2003; 16(2):101-5. PubMed ID: 12641872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplementation of Short-Chain Fatty Acid, Sodium Propionate, in Patients on Maintenance Hemodialysis: Beneficial Effects on Inflammatory Parameters and Gut-Derived Uremic Toxins, A Pilot Study (PLAN Study).
    Marzocco S; Fazeli G; Di Micco L; Autore G; Adesso S; Dal Piaz F; Heidland A; Di Iorio B
    J Clin Med; 2018 Sep; 7(10):. PubMed ID: 30274359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
    Lau WL; Savoj J; Nakata MB; Vaziri ND
    Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of oxidative stress in patients with chronic renal failure].
    González Rico M; Puchades MJ; García Ramón R; Saez G; Tormos MC; Miguel A
    Nefrologia; 2006; 26(2):218-25. PubMed ID: 16808260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
    Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
    Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oxidative stress in chronic renal failure and hemodialysis].
    Descamps-Latscha B; Witko-Sarsat V
    Nephrologie; 2003; 24(7):377-9. PubMed ID: 14650750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular mechanisms for uremic toxin-induced oxidative tissue damage via a cardiovascular-renal connection].
    Watanabe H
    Yakugaku Zasshi; 2013; 133(8):889-95. PubMed ID: 23903229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular incompetence in dialysis patients--protein-bound uremic toxins and endothelial dysfunction.
    Jourde-Chiche N; Dou L; Cerini C; Dignat-George F; Brunet P
    Semin Dial; 2011; 24(3):327-37. PubMed ID: 21682773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome.
    Lekawanvijit S
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30200452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease.
    Wang Y; Gao L
    Front Pharmacol; 2022; 13():800950. PubMed ID: 35222026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg?
    Himmelfarb J
    Semin Dial; 2004; 17(6):449-54. PubMed ID: 15660575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.
    Fujii H; Nakai K; Fukagawa M
    Ther Apher Dial; 2011 Apr; 15(2):125-8. PubMed ID: 21426501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hemodialysis on the oxidative stress and antioxidants.
    Dursun E; Ozben T; Süleymanlar G; Dursun B; Yakupoglu G
    Clin Chem Lab Med; 2002 Oct; 40(10):1009-13. PubMed ID: 12476939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.